American Healthcare REIT's strengths come from a growing portfolio and future pipeline, macro demand for senior care and ...

Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

In 2026, J&J expects accelerated growth in the Innovative Medicine segment to be driven by its key products as well as new ...

The rapid expansion of cloud-native architectures has revolutionized the development, packaging, and delivery of software. Containers now sit at the foundation ...

For Abbotsford, the median birth year was identical in both years (2001), while the average sits slightly older in the 25-26 ...

AbbVie ABBV and AstraZeneca AZN are both global healthcare companies with diversified drug portfolios. Both companies have ...

Looking for the best Software Composition Analysis tools for your DevOps team in 2025? Explore our comprehensive review of the top 7 SCA tools, their features, pricing, and integration capabilities ...

Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.

Lydia Watson, MD, serves as a real-life example of the physician pipeline she's worked to strengthen during her tenure as president and CEO of ...

The University of the West Indies, St Augustine, has launched its Artificial Intelligence Innovation Centre (AIIC), which it ...

CTSH shares rise 20% in three months as AI investments drive deal wins, booking growth and strong 2025 guidance.

Applied Digital APLD and Dell Technologies DELL are major players in the AI infrastructure space. While Applied Digital specializes in purpose-built data centres and high-performance computing ...